Cargando…

Single-Cell Identification of Melanoma Biomarkers in Circulating Tumor Cells

SIMPLE SUMMARY: Identification and investigation of cancer biomarkers is a pivotal area of modern cancer research. One such biomarker that has garnered considerable attention in the field is a class of free-floating tumor cells found in the blood known as circulating tumor cells (CTCs). Existing met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fankhauser, Reilly, Chang, Matthew, Garrison, Zachary, Berryman, Rachel, Lucero, Olivia M., Fuiten, Allison, DePatie, Nicholas, Seifert, Hilary, Kulkarni, Rajan P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564060/ https://www.ncbi.nlm.nih.gov/pubmed/36230844 http://dx.doi.org/10.3390/cancers14194921

Ejemplares similares

Advances in Early Detection of Melanoma and the Future of At-Home Testing
por: Garrison, Zachary R., et al.
Publicado: (2023)

Stakeholder‐driven principles for advancing equity through shared measurement
por: Hilliard‐Boone, Tandrea, et al.
Publicado: (2022)

Digits in a dish: An in vitro system to assess the molecular genetics of hand/foot development at single-cell resolution
por: Fuiten, Allison M., et al.
Publicado: (2023)

The Circulating Transcriptome as a Source of Biomarkers for Melanoma
por: Solé, Carla, et al.
Publicado: (2019)

Current Trends in Circulating Biomarkers for Melanoma Detection
por: Huang, Nancy, et al.
Publicado: (2022)

A Novel Potential Role for Monocytes Revealed by Single Cell Analysis of Immunotherapy Induced Immune Related Adverse Events
por: Garrison, Zachary, et al.
Publicado: (2022)

Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation
por: Kiniwa, Yukiko, et al.
Publicado: (2021)

Circulating Tumor Cells in Melanoma Patients
por: Clawson, Gary A., et al.
Publicado: (2012)

Circulating Melanoma Cells: Scoping the Target
por: Joshi, Powrnima, et al.
Publicado: (2013)

Circulating microRNAs as Candidate Biomarkers for the Surveillance of Melanoma Patients
por: Behrmann, Iris, et al.
Publicado: (2015)

Methylated circulating tumor DNA as a biomarker in cutaneous melanoma
por: Diefenbach, Russell J, et al.
Publicado: (2020)

Clinical Application of Circulating Tumor Cells and Circulating Tumor DNA in Uveal Melanoma
por: Beasley, Aaron, et al.
Publicado: (2018)

Circulating MicroRNA Biomarkers in Melanoma: Tools and Challenges in Personalised Medicine
por: Mumford, Sophie L., et al.
Publicado: (2018)

Circulating MicroRNAs as Quantitative Biomarkers for Diagnosis and Prognosis of Uveal Melanoma
por: Zhou, Wen-Da, et al.
Publicado: (2022)

BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers
por: Castellani, Giorgia, et al.
Publicado: (2023)

Detection of circulating melanoma cells in choroidal melanocytic lesions
por: Bande, Manuel F., et al.
Publicado: (2015)

Circulating Hybrid Cells Join the Fray of Circulating Cellular Biomarkers
por: Sutton, Thomas L., et al.
Publicado: (2019)

Circulating Melanoma Cell Numbers Correlate with TIGIT-Positive Cytotoxic T Cell Counts in Advanced-Stage Melanoma Patients
por: Kamińska, Paula, et al.
Publicado: (2023)

Circulating Melanoma Cell Subpopulations: Their Heterogeneity and Differential Responses to Treatment
por: Gray, Elin S, et al.
Publicado: (2015)

Enrichment of circulating melanoma cells (CMCs) using negative selection from patients with metastatic melanoma
por: Joshi, Powrnima, et al.
Publicado: (2014)

Circulating Biomarkers to Identify Responders in Cardiac Cell therapy
por: Jokerst, Jesse V., et al.
Publicado: (2017)

Mutation analysis of BRAF and KIT in circulating melanoma cells at the single cell level
por: Sakaizawa, K, et al.
Publicado: (2012)

Tumor-Related Methylated Cell-Free DNA and Circulating Tumor Cells in Melanoma
por: Salvianti, Francesca, et al.
Publicado: (2016)

Intra-Patient Heterogeneity of Circulating Tumor Cells and Circulating Tumor DNA in Blood of Melanoma Patients
por: Gorges, Katharina, et al.
Publicado: (2019)

Stem–Mesenchymal Signature Cell Genes Detected in Heterogeneous Circulating Melanoma Cells Correlate With Disease Stage in Melanoma Patients
por: Rapanotti, Maria Cristina, et al.
Publicado: (2020)

Circulating microRNAs as diagnostic biomarkers for melanoma: a systematic review and meta-analysis
por: Wu, Nan, et al.
Publicado: (2023)

Circulating endothelial cells as biomarker for cardiovascular diseases
por: Farinacci, Maura, et al.
Publicado: (2018)

Detection and prognostic role of heterogeneous populations of melanoma circulating tumour cells
por: Aya-Bonilla, Carlos Alberto, et al.
Publicado: (2020)

Identification, genetic testing, and management of hereditary melanoma
por: Leachman, Sancy A., et al.
Publicado: (2017)

A Re-evaluation of the “Oncogenic” Nature of Wnt/β-catenin Signaling in Melanoma and Other Cancers
por: Lucero, Olivia M., et al.
Publicado: (2010)

Widespread selection and gene flow shape the genomic landscape during a radiation of monkeyflowers
por: Stankowski, Sean, et al.
Publicado: (2019)

Biomarkers on melanoma patient T Cells associated with ipilimumab treatment
por: Wang, Wenshi, et al.
Publicado: (2012)

A Panel of Circulating MicroRNAs Detects Uveal Melanoma With High Precision
por: Stark, Mitchell S., et al.
Publicado: (2019)

Biomarkers in melanoma
por: Gogas, H., et al.
Publicado: (2009)

Circulating Biomarkers in Hypertrophic Cardiomyopathy
por: Matthia, Eldon L., et al.
Publicado: (2022)

Reply: On the clinical relevance of circulating endothelial cells and platelets in prostate cancer
por: Wong, C K E, et al.
Publicado: (2013)

Circulating γδ T cells in young/adult and old patients with cutaneous primary melanoma
por: Re, Francesca, et al.
Publicado: (2005)

Immunomagnetic isolation of circulating melanoma cells and detection of PD-L1 status
por: Po, Joseph W., et al.
Publicado: (2019)

Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma
por: Anand, Kartik, et al.
Publicado: (2019)

S100-EPISPOT: A New Tool to Detect Viable Circulating Melanoma Cells
por: Cayrefourcq, Laure, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gf2i1v013bkmbmgd3hf9qnri1b